Biosimilars are becoming indispensable in the management of multiple diseases although concerns still exist

  • Brian Godman Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, GlasgowG4 0RE, United Kingdom
Keywords: Adalimumab; biosimilars; demand-side measures; generics; insulin glargine; savings

Abstract

Abstract Not Available

Bangladesh Journal of Medical Science Vol.20(1) 2021 p.5-10

Downloads

Download data is not yet available.
Abstract
279
PDF
285
Published
2021-01-01
How to Cite
Godman, B. (2021). Biosimilars are becoming indispensable in the management of multiple diseases although concerns still exist. Bangladesh Journal of Medical Science, 20(1), 5-10. https://doi.org/10.3329/bjms.v20i1.50338
Section
Editorial